| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:348.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurosurgery (T.N., G.X., J.-W.P., Y.H., J.T.H., R.F.K.), Toxicology (J.-W.P.), and Physiology (R.F.K.), University of Michigan, Ann Arbor.
Correspondence to Dr Richard F. Keep, Department of Neurosurgery, University of Michigan, 5550 Kresge I, Ann Arbor, Michigan 48109-0532. E-mail rkeep{at}umich.edu
Background and Purpose Previous studies have suggested that delayed release of hemoglobin degradation products, particularly iron, is involved in intracerebral hemorrhage (ICH)induced brain injury. However, a recent study found evidence of iron-induced brain injury soon after ICH. This study, therefore, examined whether another iron-containing component of blood, holo-transferrin (holo-Tf), might also induce brain injury either alone or in combination with thrombin, another factor involved in early ICH-induced brain injury.
Methods Male Sprague-Dawley rats received an intracerebral infusion of holo-Tf, apo (nonironloaded)-Tf, thrombin, or a combination of Tf with thrombin into the right basal ganglia. The rats were euthanized 24 hours later for measurement of brain edema and assessment of DNA damage (single- and double-strand breaks and 8-hydroxyl-2'-deoxyguanosine immunohistochemistry). Iron distribution was examined histochemically.
Results Holo-Tf, apo-Tf, and the dose of thrombin used (1 U) all failed to induce brain edema when administered alone. However, the combination of holo-Tf with thrombin (but not apo-Tf with thrombin) caused brain edema, DNA damage, and intracellular iron accumulation in the ipsilateral basal ganglia.
Conclusions These results suggest that in addition to hemoglobin-bound iron, Tf-bound iron may contribute to ICH-induced brain injury and that thrombin may contribute to the latter by facilitating cellular iron uptake.
Key Words: brain edema iron oxidative stress thrombin transferrin
This article has been cited by other articles:
![]() |
M. Okauchi, Y. Hua, R. F. Keep, L. B. Morgenstern, and G. Xi Effects of Deferoxamine on Intracerebral Hemorrhage-Induced Brain Injury in Aged Rats Stroke, May 1, 2009; 40(5): 1858 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Wagner Modeling Intracerebal Hemorrhage: Glutamate, Nuclear Factor-{kappa}B Signaling and Cytokines Stroke, February 1, 2007; 38(2): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hua, R. F. Keep, J. T. Hoff, and G. Xi Brain Injury After Intracerebral Hemorrhage: The Role of Thrombin and Iron Stroke, February 1, 2007; 38(2): 759 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Keep, G. Xi, Y. Hua, and J. T. Hoff The Deleterious or Beneficial Effects of Different Agents in Intracerebral Hemorrhage: Think Big, Think Small, or Is Hematoma Size Important? Stroke, July 1, 2005; 36(7): 1594 - 1596. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |